The University of Edinburgh
Molecular effects of aspirin on NFkB in colorectal cancer
Abstract
dc:description.abstractColorectal cancer (CRC) is the most common fatal malignancy in the non-smoking population and Scotland is a high incidence country with an average number of 3445 annual registrations (1997-2001). Despite research and development in clinical practice, the overall 5-year survival is only 51%. Curative surgical resection can increase survival to 70%, but this is only applicable to patients with localised disease. One approach that holds promise in reducing overall disease mortality involves primary prevention using chemopreventive agents. Substantial evidence indicates that non-steroidal anti¬ inflammatory drugs (NSAIDs) protect against colorectal cancer, but the molecular basis is not fully elucidated. The host laboratory has previously demonstrated that aspirin-induced apoptosis in colorectal cancer cells is associated with modulation of the NFkB signalling pathway. The transcription factor NFkB regulates expression of genes involved in proliferation, apoptosis and carcinogenesis. Aspirin-induced apoptosis in colorectal cancer cells was found to be dependent on aspirin-induced degradation of IkBoi, the NFkB inhibitory protein, and NFkB nuclear translocation. Epidemiological data indicates that the protective effect of NSAIDs is greater in colorectal cancer compared to other cancer types, suggesting the possibility that aspirin might target distinct molecular pathways in colonic epithelial cells.
Degree
thesis:*- Grantor dc:publisher
- The University of Edinburgh
- Year dc:date.issued
- 2006
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Din, Farhat Vanessa Nasim
Identifiers
dc:identifier.*- Handle dc:identifier.uri
- http://hdl.handle.net/1842/29088